{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:31:07Z","timestamp":1784543467101,"version":"3.55.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Hospitals Authority","award":["XTCX201819"],"award-info":[{"award-number":["XTCX201819"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To find indicators of disease severity and factors of early remission in patients with deficiency of adenosine deaminase 2 (DADA2).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We enrolled six DADA2 patients from six families. Direct sequencing of adenosine deaminase 2 gene (ADA2) was performed by Sanger analysis. A literature review was conducted for articles regarding paediatric DADA2.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found that more organs were involved in early-onset (\u22641 year of age) than in late-onset (&amp;gt;1 year of age) DADA2 patients had high level inflammatory responses, such as elevated ESR, SF, serum amyloid A and CRP. Disease severity was not significantly different from missense and frameshift mutation. Early administration of TNF inhibitor might result in better remission and reduce recurrence. In the literature, four articles describing 51 paediatric DADA2 patients were identified. We also found that fever, stroke, peripheral nervous system involvement, hypogammaglobulinaemia and hypertension were more frequent in early onset DADA2 patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Early-onset DADA2 may be more severe. Early administration of TNF inhibitor can effectively reduce recurrence and quickly alleviate the disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac233","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T11:10:44Z","timestamp":1650712244000},"page":"969-976","source":"Crossref","is-referenced-by-count":4,"title":["Early onset is an indication of the severity of DADA2 disease"],"prefix":"10.1093","volume":"62","author":[{"given":"Xiaozhen","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2549-7493","authenticated-orcid":false,"given":"Shipeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Centre for Children\u2019s Health; Beijing Children\u2019s Hospital, Capital Medical University , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"2023020117331898400_keac233-B1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1756-185X.13283","article-title":"Diagnosis and management of ADA2 deficient polyarteritis nodosa","volume":"22(Suppl 1)","author":"Human","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2023020117331898400_keac233-B2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3899\/jrheum.181384","article-title":"A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2","volume":"47","author":"\u00d6zen","year":"2020","journal-title":"J Rheumatol"},{"key":"2023020117331898400_keac233-B3","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1007\/s10067-020-05210-4","article-title":"Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review","volume":"39","author":"Ganh\u00e3o","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2023020117331898400_keac233-B4","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)","volume":"145","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2023020117331898400_keac233-B5","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jaci.2020.04.023","article-title":"Deficiency of adenosine deaminase 2: is it an elephant after all?","volume":"145","author":"Schnappauf","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2023020117331898400_keac233-B6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of Adenosine Deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol"},{"key":"2023020117331898400_keac233-B7","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1007\/s10067-021-05711-w","article-title":"Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment","volume":"40","author":"Pinto","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2023020117331898400_keac233-B8","doi-asserted-by":"crossref","first-page":"578700","DOI":"10.3389\/fimmu.2021.578700","article-title":"Plasma Adenosine Deaminase (ADA)-1 and -2 demonstrate robust ontogeny across the first four months of human life","volume":"12","author":"Odumade","year":"2021","journal-title":"Front Immunol"},{"key":"2023020117331898400_keac233-B9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12917-020-02574-2","article-title":"Characterization of total adenosine deaminase activity (ADA) and its isoenzymes in saliva and serum in health and inflammatory conditions in four different species: an analytical and clinical validation pilot study","volume":"16","author":"Contreras-Aguilar","year":"2020","journal-title":"BMC Vet Res"},{"key":"2023020117331898400_keac233-B10","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023020117331898400_keac233-B11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000495794","article-title":"Adenosine deaminase two and immunoglobulin M accurately differentiate adult Sneddon's syndrome of unknown cause","volume":"46","author":"Santo","year":"2018","journal-title":"Cerebrovasc Dis"},{"key":"2023020117331898400_keac233-B12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s12098-021-03809-2","article-title":"Deficiency of Adenosine Deaminase 2 (DADA2): one disease, several faces","volume":"88","author":"Pimpale Chavan","year":"2021","journal-title":"Indian J Pediatr"},{"key":"2023020117331898400_keac233-B13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/art.40913","article-title":"Identification of novel adenosine deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis","volume":"71","author":"Gibson","year":"2019","journal-title":"Arthritis Rheumatol (Hoboken)"},{"key":"2023020117331898400_keac233-B14","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1093\/rheumatology\/keaa837","article-title":"Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)","volume":"60","author":"Cooray","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023020117331898400_keac233-B15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12969-019-0334-5","article-title":"Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2)","volume":"17","author":"Clarke","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"2023020117331898400_keac233-B16","first-page":"480","article-title":"Mutant ADA2 in vasculopathies","volume":"371","author":"Van Eyck","year":"2014","journal-title":"N Engl J Med"},{"key":"2023020117331898400_keac233-B17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1546-0096-12-44","article-title":"Mutations in CECR1 associated with a neutrophil signature in peripheral blood","volume":"12","author":"Belot","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"2023020117331898400_keac233-B18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"2023020117331898400_keac233-B19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac233\/43796988\/keac233.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/969\/49031598\/keac233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/969\/49031598\/keac233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:43:39Z","timestamp":1675298619000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/2\/969\/6574347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,4,26]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac233","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,4,26]]}}}